GlassScriptPhysician profile
Sami A Issa
NPI 1558356014
$421.65
in general payments reported to CMS, 2019-2025
14 companies · $95.37 in 2025
The $95.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.84 · 2020: $54.96 · 2021: $22.14 · 2022: $92.03 · 2023: $52.02 · 2024: $59.29 · 2025: $95.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $69.81 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $57.32 | 2019-2022 | |
| Abbvie INC. | $57.30 | 2023-2025 | |
| Medtronic, INC. | $36.22 | 2023 | Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $30.80 | 2025 | Infinion 16 |
| Hologic Sales and Service, LLC | $24.15 | 2025 | Thinprep 2000 Processor, Aptima |
| Novartis Pharmaceuticals Corporation | $23.38 | 2022 | |
| Novo Nordisk INC | $22.14 | 2021 | |
| Lilly USA, LLC | $19.99 | 2020 | |
| Merck Sharp & Dohme LLC | $18.70 | 2020 | |
| Globus Medical, INC. | $18.57 | 2025 | Senza |
| Allergan, INC. | $16.27 | 2020 | |
| Pfizer INC. | $13.53 | 2019 | |
| Aimmune Therapeutics, INC. | $13.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Issa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.